Monday, October 22, 2007 8:43:57 PM
http://biz.yahoo.com/pz/071022/129302.html
Press Release Source: Balchem Corporation
Balchem Corporation Announces Third Quarter 2007 Results and Quarterly Conference Call On November 5, 2007 At 2:00 PM ET
Monday October 22, 2:00 pm ET
NEW HAMPTON, N.Y., Oct. 22, 2007 (PRIME NEWSWIRE) -- Balchem Corporation (NasdaqGS:BCPC - News) today announced that a conference call will be held on Monday, November 5 at 2:00 PM Eastern Time (ET) to review third quarter and year-to-date 2007 results. Dino A. Rossi, President and CEO, and Frank Fitzpatrick, Chief Financial Officer, will host the call.
Quarterly results will be released to the market on Monday, November 5, at 9:30 AM (ET). The press release, and its accompanying financial exhibits, will also be available on the Company website, http://www.balchem.com, prior to the conference call.
We invite you to listen to the call by dialing toll-free (877) 407-8289 (Event #8) five minutes prior to the scheduled start time of the conference call. The conference call will be available for digital replay through Friday, November 9. To access the replay of the conference call, dial (877) 660-6853, use account #298 and conference ID#259297. Both account and conference ID numbers are required for replay access.
About Balchem Corporation
Balchem Corporation consists primarily of three business segments: ARC Specialty Products, Encapsulated/Nutritional Products, and BCP Ingredients, our unencapsulated feed supplements segment. Through ARC Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries. The Encapsulated/Nutritional segment provides proprietary microencapsulation solutions to an expanding variety of applications. BCP Ingredients manufactures and supplies choline chloride and derivatives used primarily in the poultry and swine industries.
Contact:
Balchem Corporation
Karin McCaffery, Executive Administration Manager
845-326-5600
kmccaffery@balchemcorp.com
Your trading and investment choices should be the result of your own due diligence.
Recent BCPC News
- Balchem Corporation Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/03/2024 11:00:00 AM
- New York Jets Announce Multi-Year Partnership with VitaCholine® • GlobeNewswire Inc. • 05/02/2024 12:00:00 PM
- Balchem Corporation to Attend the BMO 19th Annual Global Farm to Market Conference on May 16, 2024 • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Balchem Corporation Releases 2023 Sustainability Report • GlobeNewswire Inc. • 04/22/2024 11:00:00 AM
- Balchem Corporation Announces Quarterly Conference Call for First Quarter Financial Results on May 3, 2024 • GlobeNewswire Inc. • 04/19/2024 11:00:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/08/2024 11:18:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:30:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2024 10:32:14 PM
- Balchem Corporation to Participate at the BNP Paribas Exane 12th Consumer Ingredients Conference on March 14, 2024 • GlobeNewswire Inc. • 02/29/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 09:58:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 09:57:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:11:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:41:17 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 09:37:35 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 10:08:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 10:12:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 10:12:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/21/2024 09:55:41 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/16/2024 10:26:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 12:14:27 PM
- Balchem Corporation Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/16/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 12:09:37 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:58:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:55:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/13/2024 10:00:07 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM